Evidence map›Paper›PMID 41012102›Full record

ArticleVaccines2025

Acceptance of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Neonates: A Cross-Sectional Survey in Emilia-Romagna, Italy.

Susanna Esposito, Valentina Fainardi, Maria Elena Capra, Melodie Aricò, Angela Lanzoni, Beatrice Rita Campana, Marta Niceforo, Cosimo Neglia, Enrico Valletta, Giacomo Biasucci and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Susanna EspositoPediatric Clinic, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0003-4103-2837
Valentina FainardiPediatric Clinic, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0003-4601-7484
Maria Elena CapraPediatrics and Neonatology Unit, Guglielmo da Saliceto Hospital, 29100 Piacenza, Italy.ORCID 0000-0003-0848-5228
Melodie AricòPediatric Unit, G.B. Morgagni-L. Pierantoni Hospital, AUSL Romagna, 47100 Forlì, Italy.ORCID 0000-0003-2072-3559
Angela LanzoniPediatric Unit, Santa Maria della Scaletta Hospital, 40026 Imola, Italy.
Beatrice Rita CampanaPediatric Clinic, University Hospital of Parma, 43126 Parma, Italy.
Marta NiceforoPediatric Clinic, University Hospital of Parma, 43126 Parma, Italy.
Cosimo NegliaPediatric Clinic, University Hospital of Parma, 43126 Parma, Italy.
Enrico VallettaPediatric Unit, G.B. Morgagni-L. Pierantoni Hospital, AUSL Romagna, 47100 Forlì, Italy.
Giacomo BiasucciPediatrics and Neonatology Unit, Guglielmo da Saliceto Hospital, 29100 Piacenza, Italy.ORCID 0000-0002-7441-9248
Serafina PerroneNeonatology, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0001-5478-5657

Funding

NextGenerationEU CUP I83C22001810007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

monoclonal antibodiesnirsevimabparental acceptancerespiratory syncytial virus (RSV)

Identifiers

PMID41012102
PMCPMC12474476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.